|
Volumn 20, Issue 18, 2006, Pages 2390-2392
|
Immune reconstitution inflammatory syndrome in the first year after HAART: Influence on long-term clinical outcome
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL FEATURE;
CONTROLLED STUDY;
EVENT FREE SURVIVAL RATE;
FEMALE;
HERPES ZOSTER;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
IMMUNE RESPONSE;
INFLAMMATION;
KAPLAN MEIER METHOD;
MAJOR CLINICAL STUDY;
MALE;
NONHUMAN;
OPPORTUNISTIC INFECTION;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
TUBERCULOSIS;
VIRUS LOAD;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
FEMALE;
HIV INFECTIONS;
HUMANS;
IMMUNE SYSTEM DISEASES;
KAPLAN-MEIERS ESTIMATE;
MALE;
RETROSPECTIVE STUDIES;
SYNDROME;
TREATMENT OUTCOME;
|
EID: 33751205318
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/QAD.0b013e328010f201 Document Type: Article |
Times cited : (33)
|
References (8)
|